SCHEMBL7984769

SCHEMBL7984769

Cc1ccc(Cn2cnc3nc(-c4cccnc4)nc(O)c32)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CLK4 Q9HAZ1 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.43
KMT2A Q03164 3/20 0.41
MEN1 O00255 1/20 0.41
KDR P35968 1/20 0.41
EPHB4 P54760 1/20 0.41
GBA1 P04062 2/20 0.40
DHPS P49366 1/20 0.40
HTT P42858 5/20 0.39
SMN1; SMN2 Q16637 4/20 0.39
LMNA P02545 3/20 0.39
HSD17B10 Q99714 1/20 0.39
ALDH1A1 P00352 2/20 0.39
NPSR1 Q6W5P4 2/20 0.39
TP53 P04637 1/20 0.39
NFKB1 P19838 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7974286 0.90 DHPS (0.49) CLK4L3MBTL1KMT2AMEN1GBA1
SCHEMBL7989420 0.89 MET (0.45) DHPSSMN1; SMN2LMNAHSD17B10TP53
SCHEMBL7988934 0.89 CYP1A2 (0.47) KMT2AMEN1KDRDHPSSMN1; SMN2
SCHEMBL7974237 0.89 KIF11 (0.42) KMT2AMEN1DHPSHTTSMN1; SMN2
SCHEMBL7984717 0.88 SMN1; SMN2 (0.46) KMT2AMEN1HTTSMN1; SMN2LMNA
SCHEMBL7985826 0.86 NPC1 (0.41) KMT2AMEN1HTTSMN1; SMN2LMNA
SCHEMBL7988659 0.84 P2RX7 (0.41) L3MBTL1KDRDHPSHTTSMN1; SMN2
SCHEMBL7985565 0.83 HDAC6 (0.40) KMT2AMEN1HTTSMN1; SMN2LMNA
SCHEMBL7984423 0.83 SMN1; SMN2 (0.38) KMT2AMEN1HTTSMN1; SMN2LMNA
SCHEMBL7991597 0.83 PDE4B (0.39) L3MBTL1HTTSMN1; SMN2LMNAHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed